Mutational analysis of caspase 1, 4, and 5 genes in common human cancers

Human Pathology

Volumn 39, Issue 6, 2008, Pages 895-900

  Soung, Young Hwa ^a   Jeong, Eun Goo ^a   Ahn, Chang Hyeok ^a   Kim, Sung Soo ^a   Song, Sang Yong ^b   Yoo, Nam Jin ^a   Lee, Sug Hyung ^a  

^a The Catholic University of Korea   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Apoptosis; Cancer; Caspase 1; Caspase 4; Caspase 5; Mutation

Indexed keywords

CASPASE 4; CASPASE 5; INTERLEUKIN 1BETA CONVERTING ENZYME;

ARTICLE; BREAST CARCINOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; EXON; FRAMESHIFT MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; LUNG CARCINOMA; MICROSATELLITE INSTABILITY; MISSENSE MUTATION; MUTATIONAL ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; SOMATIC MUTATION; STOMACH CARCINOMA;

APOPTOSIS; CASPASE 1; CASPASES; CASPASES, INITIATOR; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; HUMANS; MALE; MICROSATELLITE INSTABILITY; NEOPLASMS;

EID: 44649139105     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2007.10.015     Document Type: Article

References (27)

1. Reed J.C. Mechanisms of apoptosis. Am J Pathol 39 (2000) 1415-1430
2. Nagata S. Apoptosis by death factor. Cell 88 (1997) 355-365
3. Nicholson D.W. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ 6 (1999) 1028-1042
4. Kumar S. Mechanisms mediating caspase activation in cell death. Cell Death Differ 6 (1999) 1060-1066
5. Thornberry N.A., Bull H.G., Calaycay J.R., et al. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356 (1992) 768-774
6. Munday N.A., Vaillancourt J.P., Ali A., et al. Molecular cloning and proapoptotic activity of ICErelII and ICErelIII, members of the ICE/CED-3 family of cysteine proteases. J Biol Chem 270 (1995) 15870-15876
7. Kamens J., Paskind M., Huqunin M., et al. Identification and characterization of ICH-2, a novel member of the interleukin-1 beta-converting enzyme family of cysteine proteases. J Biol Chem 270 (1995) 15250-15256
8. Martinon F., and Tschopp J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 117 (2004) 561-574
9. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
10. Lee S.H., Shin M.S., Park W.S., et al. Alterations of Fas;Apo-1/CD95;gene in non-small cell lung cancer. Oncogene 18 (1999) 754-760
11. Kurokawa H., Nishio K., Fukumoto H., Tomonari A., Suzuki T., and Saijo N. Alteration of caspase-3;CPP32/Yama/apopain;in wild-type MCF-7, breast cancer cells. Oncol Rep 6 (1999) 33-37
12. Schwartz Jr. S., Yamamoto H., Navarro M., Maestro M., Reventos J., and Perucho M. Frameshift mutations at mononucleotide repeats in caspase-5 and other target genes in endometrial and gastrointestinal cancer of the microsatellite mutator phenotype. Cancer Res 59 (1999) 2995-3002
13. Offman J., Gascoigne K., Bristow F., et al. Repeated sequences in CASPASE-5 and FANCD2 but not NF1 are targets for mutation in microsatellite-unstable acute leukemia/myelodysplastic syndrome. Mol Cancer Res 3 (2005) 251-260
14. Hosomi Y., Gemma A., Hosoya Y., et al. Somatic mutation of the caspase-5 gene in human lung cancer. Int J Mol Med 12 (2003) 443-446
15. Lee J.W., Kim M.R., Soung Y.H., et al. Mutational analysis of the CASP6 gene in colorectal and gastric carcinomas. APMIS 114 (2006) 646-650
16. Soung Y.H., Lee J.W., Kim H.S., et al. Inactivating mutations of CASPASE-7 gene in human cancers. Oncogene 22 (2003) 8048-8052
17. Mandruzzato S., Brasseur F., Andry G., Boon T., and van der Bruggen P. A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma. J Exp Med 186 (1997) 785-793
18. Kim H.S., Lee J.W., Soung Y.H., et al. Inactivating mutations of caspase-8 gene in colorectal carcinomas. Gastroenterology 125 (2003) 708-715
19. Soung Y.H., Lee J.W., Kim S.Y., et al. CASPASE-8 gene is inactivated by somatic mutations in gastric carcinomas. Cancer Res 65 (2005) 815-821
20. Soung Y.H., Lee J.W., Kim S.Y., et al. Mutational analysis of proapoptotic caspase-9 gene in common human carcinomas. APMIS 114 (2006) 292-297
21. Shin M.S., Kim H.S., Kang C.S., et al. Inactivating mutations of CASP10 gene in non-Hodgkin lymphomas. Blood 99 (2002) 4094-4099
22. Edmondson H.A., and Steiner P.E. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7 (1954) 462-503
23. Lee S.H., Stehlik C., and Reed J.C. Cop, a caspase recruitment domain-containing protein and inhibitor of caspase-1 activation processing. J Biol Chem 276 (2001) 34495-34500
24. Boland C.R., Thibodeau S.N., Hamilton S.R., et al. A National Cancer Institute Workshop on Microsatellite Instability for Cancer Detection and Familial Predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58 (1998) 5248-5257
25. Futreal P.A., Coin L., Marshall M., et al. A census of human cancer genes. Nat Rev Cancer 4 (2004) 177-183
26. Krawczak M., Reiss J., and Cooper D.N. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: cause and consequences. Hum Genet 90 (1992) 41-54
27. Aggarwal B.B. Nuclear factor-kappaB: the enemy within. Cancer Cell 6 (2004) 203-208